16:58 · 10 July 2023

BREAKING:Novavax on the wave after receiving $350 million for unused COVID shots📈

Novavax
Shares
NVAX.US, Novavax Inc
-
-

Novavax's (NVAX.US) share price jumped more than 20% after the biotech company said Canada had agreed to pay $350 million for Covid vaccines that were previously due to be delivered. The settlement, in the case of NVAX, is significant because the company's management expressed doubts about its viability earlier in the year. 

According to the SEC filing, the Canadian government's payment will be made in two equal instalments in 2023. It is worth mentioning that the vaccines for Covid-19 are the company's only commercial product. 

The company's shares are currently testing the limitation formed by the 100-day exponential moving average (purple curve). Source: xStation 5

8 October 2025, 17:58

UBS raises Micron’s price target. Shares are rising!

8 October 2025, 15:19

US OPEN: Wall Street not afraid of Shutdown 📈💲

8 October 2025, 14:27

Phew, the rally is back on, as AI boom continues

8 October 2025, 07:05

Gold powers to fresh record, as stocks slip, but there could still be further upside to come

This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.

Join over 1.7 Million investors from around the world